Feb 06, 2013 (M2 PRESSWIRE via COMTEX) --
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 7th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. Net 1 UEPS Technologies Inc (NASDAQ:UEPS), Gleacher And Co Inc (NASDAQ:GLCH), Unilife Corp (NASDAQ:UNIS), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), DCT Industrial Trust Inc (NYSE:DCT), Euroseas Ltd (NASDAQ:ESEA) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
Symbol Company # of Reports Quarter Release Time
UEPS Net 1 UEPS Technologies Inc 6 Quarter Q2 After
GLCH Gleacher And Co Inc 12 Quarter Q4 After
UNIS Unilife Corp 12 Quarter Q2 After
AVNR Avanir Pharmaceuticals Inc 12 Quarter Q1 After
DCT DCT Industrial Trust Inc 6 Quarter Q4 After
ESEA Euroseas Ltd 12 Quarter Q4 After
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Net 1 UEPS Technologies Inc (NASDAQ:UEPS) - Net 1 Ueps Technologies Inc. provides payment solutions and transaction processing services for various industries in South Africa, Korea, Europe, and internationally. It offers universal electronic payment system (UEPS), a smart-card based alternative payment system for the unbanked and underbanked populations of developing economies. The company s UEPS system allows card holders to transact at any EMV-enabled point of sale terminal or ATM; and can be used for banking, health care management, international money transfers, voting, and identification. It provides state pension and welfare distribution service to the South African government; transactions processing services for retailers, utilities, banks, and medical-related claim service customers, as well as bill payments and prepaid electricity for bill issuers and local councils; and mobile telephone top-up transactions for mobile carriers. The company also offers payment processing services to merchants and card issuers; transaction processing of UEPS-enabled smartcards and medical-related claims; and clinical risk management solutions. In addition, it provides smart card accounts; financial services, including short-term loans, microfinance, life insurance, and money transfer products; and on-line real-time management system services for healthcare transactions, as well as processes third-party payroll payments for employees. Further, the company markets, sells, and implements the UEPS; provides Prism secure transaction technology, solutions, and services, as well as is involved in hardware and SIM Card sales, and licensing the DUET system, SIM card, and other software; undertakes smart card system implementation projects; delivers hardware, software, and business solutions; provides cryptography services; and rents hardware to merchants. Net 1 UEPS Technologies, Inc. was founded in 1989 and is headquartered in Johannesburg, South Africa..
Gleacher And Co Inc (NASDAQ:GLCH) - Gleacher & Company, Inc., an independent investment bank, provides corporate and institutional clients with strategic and financial advisory services, including merger and acquisition, restructuring, recapitalization, and strategic alternative analysis. The company operates through four segments: Mortgage Backed/Asset Backed & Rates (MBS/ABS & Rates), Corporate Credit, Investment Banking, and ClearPoint. The MBS/ABS & Rates segment provides sales, trading, research, and advisory services on a range of mortgage and asset-backed securities; U.S. treasury and government agency securities; and structured products, such as collateralized loan obligations and collateralized debt obligations, whole loans, and other securities. The Corporate Credit segment offers analysis, sales, and trading on various debt securities, including bank debt and loans, investment grade debt, high-yield debt, treasuries, convertibles, distressed debt, preferred debt, emerging market debt, and reorganization equities to corporate and institutional investor clients. This segment also provides trade execution services, liability management, corporate debt repurchase programs, and new issue distribution services. The Investment Banking segment provides financial advisory and capital raising services in connection with mergers, acquisitions, and other strategic matters. The ClearPoint segment originates, processes, and underwrites single and multi-family residential mortgage loans in 43 states. Gleacher & Company, Inc., formerly known as Broadpoint Gleacher Securities Group, Inc., was founded in 1952 and is headquartered in New York, New York..
Unilife Corp (NASDAQ:UNIS) - Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company s principal product is the Unifill ready-to-fill syringe, which is designed for pharmaceutical manufacturers in a ready form for filling with their injectable drugs and vaccines. It also offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select glass prefilled syringe, which facilitates the use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unitract 1mL syringes for use in healthcare facilities and by patients who self-administer prescription medication, such as insulin. In addition, the company provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. Further, it offers the Precision-Therapy range of bolus injectors for use with bolus-based therapies that require short or long duration injections; and the Flex-Therapy range of bolus injectors for use with rate-based therapies that require infusion over a longer duration of time where the delivery rate is controlled for hours or days. Additionally, the company provides specialized device technology platforms comprising devices for targeted organ delivery, low dose delivery systems, and implant deployment systems for the administration of an implantable drug through an intravitreal or intraocular injection. Its customers also include pharmaceutical and biotechnology companies; and suppliers of combination drug-delivery devices to government agencies. The company is headquartered in York, Pennsylvania..
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) - Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. The company s clinical development stage products comprise AVP-923, which is in Phase II clinical trials for the treatment of central neuropathic pain in patients with multiple sclerosis; Phase II clinical trials for the treatment of agitation in patients with Alzheimer s disease; and Phase II clinical trials for the treatment of levodopa-induced-dyskinesia in Parkinson s disease, as well as completed Phase III trials for the treatment of patients with diabetic peripheral neuropathic pain. It also offers AVP-786 that is in Phase I clinical trial to assess the single and multiple dose pharmacokinetics, safety, and tolerability to healthy subjects. The company has a license agreement with Concert Pharmaceuticals, Inc. to develop and commercialize deuterium-modified dextromethorphan for the potential treatment of neurologic and psychiatric disorders, as well as rights to other deuterium-modified dextromethorphan compounds. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California..
DCT Industrial Trust Inc (NYSE:DCT) - DCT Industrial Trust Inc. operates as a publicly owned real estate investment trust. The firm provides its services to companies. Through its fund, it engages in the ownership, operation, and development of real estate properties. The firm specializes in the ownership, acquisition, development, and management of institutional capital management program. It invests in the real estate markets of United States and Mexico. The firm is also invests in selected international markets. It primarily invests in commercial real estate properties, including generic distribution warehouses and light industrial properties. The firm was formerly known as Dividend Capital Trust Inc. DCT Industrial Trust was founded in 2002 and is based in Denver, Colorado with additional offices in Atlanta, Georgia and Dallas, Texas..
Euroseas Ltd (NASDAQ:ESEA) - Euroseas Ltd., together with its subsidiaries, provides ocean-going transportation services worldwide. The company owns and operates dry bulk carriers that transport bulks, such as iron ore, coal, and grains, as well as minor bulks, which include bauxite, phosphate, and fertilizers. It also owns and operates containerships and multipurpose vessels that transport dry and refrigerated containerized cargoes, primarily manufactured products and perishables. As of March 19, 2012, the company s fleet consisted of 15 vessels, including 4 Panamax drybulk carriers and 1 Handymax drybulk carrier, 3 Intermediate containership, 4 Handysize containerships, 2 Feeder containerships, and a multipurpose dry cargo vessel. Its drybulk carriers had a total cargo capacity of 331,808 dwt; containerships had a cargo capacity of 15,855 teu; and multipurpose vessels had a cargo capacity of 22,568 dwt or 950 teu. The company was founded in 2005 and is based in Maroussi, Greece..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com.